IRADIMED CORP reported second-quarter 2026 results with revenue of $20.47M, roughly flat year‑over‑year, while net income and diluted EPS declined to $5.22M and $0.41, respectively, reflecting margin pressure from new-product production.Financial HighlightsBusiness HighlightsOriginal SEC Filing: IR…
Q2 revenue reached $20.5M with strong demand for the new 3870 MRI IV pump, especially quad systems, driving bookings to more than double shipments. Gross margin dipped to 74% due to ramp-up costs but is expected to recover as efficiencies improve. Full-year guidance is reaffirmed.Based on iRadimed…
Iradimed reported Q2 revenue of $20.5 million and GAAP diluted EPS of $0.41 while declaring a $0.20 quarterly dividend.Key Highlights:Original SEC Filing: IRADIMED CORP [ IRMD ] - 8-K - Jul. 31, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information…
ORLANDO, Fla., July 24, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION NASDAQ:IRMD announced today that the Company will release its 2026 second quarter financial results before the market opens on Friday, July 31, 2026. Iradimed management will host a conference call the same day beginning at 11:00…
